Global Epilepsy Monitoring Devices Market Insights, Size and Growth Forecast To 2030

COVID-19
Epilepsy Monitoring Devices Market Size, Share & Trends Analysis By Product, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Request COVID-19
impact analysis

Epilepsy Monitoring Devices Market Size, Share & Trends Analysis By Product, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Feb 2022 Base Year: 2021 Report ID: MEDE2206
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 217
Category : Medical Devices
Global epilepsy monitoring devices market is projected to be worth USD 724 million by 2030



According to SPER Market Research, the epilepsy monitoring devices market estimated to reach USD 724 million by 2030 with a CAGR of 4.5%. Epilepsy is the most common neurological disorder affecting people of all age groups. Global burden of epilepsy is around 50 million out of which 80% patients reside in low- or middle-income countries who majorly do not get timely treatment.  

Impact of COVID-19 on the Epilepsy Monitoring Devices Market
During the COVID-19 pandemic, many hospitals suspended the neurology procedures temporarily. The procurement of products was also difficult for indications other than COVID-19 due to disruption of supply chain. The fluctuations in the logistics supply cost will continue to last until COVID-19 cases continue to rise. The rising demand for wearable monitoring devices is expected to grow this market for wearable segment considering the social distancing norms.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Product, By End User
 Geographies covered North America, Europe, APAC, Latin America and the Middle East & Africa
 Companies CoveredAbbott Laboratories Inc., Advanced Brain Monitoring, Aleva Neurotherapeutics, BioSerenity, Boston Scientific Corporation, Cadwell Industries Inc., CGX, Compumedics Limited, Drägerwerk AG & Co. KGaA, Emotiv, Empatica Inc., Lifelines Neuro Company LLC, LivAssured B.V., Masimo Corporation, MC10, Inc., Medpage, Ltd., Medtronic Plc, Mindray Medical International Ltd., Mitsar Co. Ltd., mjn Neuroserveis S.L., Natus Medical Inc., Neurosoft, NeuroWave Systems Inc., Nihon Kohden Corporation, Rimed, The Magstim Co. Ltd
Driver: Rising prevalence of Epilepsy
Due to the rise in occurrence of malaria, road accidents, birth related injuries and stressful lifestyles can potentially increase the risk to epilepsy. The low middle income countries are more prone to incidence of epilepsy in population due to unmet needs in healthcare infrastructure and less awareness. Thus, rising prevalence of epilepsy can significantly drive the growth of this market. 

Challenge: High cost of devices 
The adoption of epilepsy monitoring devices can be restricted due to high cost, maintenance charges, complex mechanisms requiring trained technicians and poor reimbursement scenarios in developing countries. Thus, high cost of these devices along with maintenance and indirect costs can pose significant challenge to this market during the forecast period. 



Opportunity: Rising demand for minimally invasive procedures
With rising awareness, more patients are opting for minimally invasive procedures. Epilepsy monitoring devices overcome the risks and pain associated with invasive monitoring for brain. Many government initiatives are also focused on reducing the risks related to treatment options for brain disorders. The rise in demand creates growth opportunities for this market.

Epilepsy Monitoring Devices Market by Product:
Based on product, market has been segmented into conventional devices and wearable devices. 

Epilepsy Monitoring Devices Market by End User:
Based on end user, the market is segmented into hospitals & clinics, home care settings and others.
Hospitals & Clinics have the largest share of this market by end user due to high number of patients visiting hospitals and clinics for neurological disorders. 

Epilepsy Monitoring Devices Market by Region:
North America owns the largest share of this market due to factors such as supportive reimbursement policies, effective government initiatives, rising prevalence of neurological disorders and focus on Research and Development. 
Asia Pacific is expected to show the fastest growth in this market owing to rising awareness, increasing medical tourism, presence of large patient pool and technological advancements.

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Epilepsy Monitoring Devices Market
4.4. Market Trends

5. Global Epilepsy Monitoring Devices Market, By Product (USD Million)
5.1. Conventional Devices
5.2. Wearable Devices

6. Global Epilepsy Monitoring Devices Market, By End User (USD Million)
6.1. Hospitals and clinics
6.2. Home care settings
6.3. Others

7. Global Epilepsy Monitoring Devices Market, By Geography (USD Million)
7.1. North America
7.1.1. US
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. UK
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia-Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. Latin America
7.4.2. Middle East & Africa

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis, By Key Players
8.3. Competitive Scenario 
8.3.1. Product Launches
8.3.2. Partnerships, Collaborations and Agreements
8.3.3. Acquisitions
8.3.4. Expansions
8.3.5. Other Developments

9. Company Profiles
9.1. Abbott Laboratories, Inc.
9.2. Advanced Brain Monitoring
9.3. Aleva Neurotherapeutics
9.4. BioSerenity
9.5. Boston Scientific Corporation
9.6. Cadwell Industries, Inc.
9.7. CGX
9.8. Compumedics Limited
9.9. Drägerwerk AG & Co. KGaA
9.10. Emotiv
9.11. Empatica, Inc.
9.12. Lifelines Neuro Company, LLC
9.13. LivAssured B.V.
9.14. Masimo Corporation
9.15. MC10, Inc.
9.16. Medpage, Ltd.
9.17. Medtronic Plc
9.18. Mindray Medical International Ltd.
9.19. Mitsar Co., Ltd.
9.20. mjn Neuroserveis S.L.
9.21. Natus Medical, Inc.
9.22. Neurosoft
9.23. NeuroWave Systems, Inc.
9.24. Nihon Kohden Corporation
9.25. Rimed
9.26. The Magstim Co. Ltd.

10. Appendix

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us